511
Views
19
CrossRef citations to date
0
Altmetric
Drug Profile

Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson’s disease: focus on levodopa/carbidopa/entacapone

&
Pages 119-131 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhan-Miao Yi, Ting-Ting Qiu, Yuan Zhang, Na Liu & Suo-Di Zhai. (2018) Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson’s disease: systematic review, meta-analysis, and economic evaluation. Therapeutics and Clinical Risk Management 14, pages 709-719.
Read now
Johan Lökk, Sara Olofsson & Ulf Persson. (2014) Willingness to pay for a new drug delivery in Parkinson patients. Journal of Multidisciplinary Healthcare 7, pages 431-440.
Read now

Articles from other publishers (17)

Jing Tian, Eric Du, Kun Jia, Tienju Wang, Lan Guo, Jeffrey M. Zigman & Heng Du. (2023) Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-β Knockin Mice During Aging. Journal of Alzheimer's Disease 96:4, pages 1579-1592.
Crossref
Faezeh Shahdost-Fard, Arafeh Bigdeli & Mohammad Reza Hormozi-Nezhad. (2021) A Smartphone-Based Fluorescent Electronic Tongue for Tracing Dopaminergic Agents in Human Urine. ACS Chemical Neuroscience 12:17, pages 3157-3166.
Crossref
Li Gan, Zhengyu Li, Qiankun Lv & Wei Huang. (2019) Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson’s disease model. International Journal of Pharmaceutics 567, pages 118449.
Crossref
Geneviève N. Olivier, Serene S. Paul, Keith R. Lohse, Christopher S. Walter, Sydney Y. Schaefer & Leland E. Dibble. (2019) Predicting Motor Sequence Learning in People With Parkinson Disease. Journal of Neurologic Physical Therapy 43:1, pages 33-41.
Crossref
Santiago Perez-Lloret & Olivier Rascol. (2018) Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia. Journal of Neural Transmission 125:8, pages 1237-1250.
Crossref
William Langhoff, Alexander Riggs & Peter Hinow. (2018) Scaling behavior of drug transport and absorption in in silico cerebral capillary networks. PLOS ONE 13:7, pages e0200266.
Crossref
Angelo Antonini, Elena Moro, Clecio Godeiro & Heinz Reichmann. (2018) Medical and surgical management of advanced Parkinson's disease. Movement Disorders 33:6, pages 900-908.
Crossref
Peijian Yue, Lin Gao, Xuejing Wang, Xuebing Ding & Junfang Teng. (2018) Ultrasound‐triggered effects of the microbubbles coupled to GDNF‐ and Nurr1‐loaded PEGylated liposomes in a rat model of Parkinson's disease. Journal of Cellular Biochemistry 119:6, pages 4581-4591.
Crossref
Muhammad Abid Sheikh, Yousra Saeed Malik, Zhenkai Xing, Zhaopei Guo, Huayu Tian, Xiaojuan Zhu & Xuesi Chen. (2017) Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD). Acta Biomaterialia 54, pages 58-68.
Crossref
Mark R. Cookson. 2017. Disease-Modifying Targets in Neurodegenerative Disorders. Disease-Modifying Targets in Neurodegenerative Disorders 157 174 .
Peter A. LeWitt, Werner Poewe, Lawrence W. Elmer, Mahnaz Asgharnejad, Babak Boroojerdi, Frank Grieger & Lars Bauer. (2016) The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease. Clinical Neuropharmacology 39:2, pages 88-93.
Crossref
Yan A. Ivanenkov, Mark S. Veselov, Nina V. Chufarova, Alexander G. Majouga, Anna A. Kudryavceva & Alexandre V. Ivachtchenko. (2015) Non-dopamine receptor ligands for the treatment of Parkinson’s disease. Insight into the related chemical/property space. Molecular Diversity 20:1, pages 345-365.
Crossref
Li-Sheng Li. (2015) Effect of entacapone on colon motility and ion transport in a rat model of Parkinson’s disease. World Journal of Gastroenterology 21:12, pages 3509.
Crossref
Heinz Reichmann & Roongroj Bhidayasiri. (2014) Nocturnal manifestations of Parkinson’s disease and atypical Parkinsonism. Journal of Neural Transmission 121:S1, pages 1-2.
Crossref
Mi-Suk Lee, Yu-Gyeong Park & Na-Young Bae. (2013) A Case Study of a Taeeumin Patient with Advanced Parkinson's Disease Diagnosed as Dry-heat Symptomatic Pattern. Journal of Sasang Constitutional Medicine 25:4, pages 442-453.
Crossref
Rongqin Huang, Haojun Ma, Yubo Guo, Shuhuan Liu, Yuyang Kuang, Kun Shao, Jianfeng Li, Yang Liu, Liang Han, Shixian Huang, Sai An, Liya Ye, Jinning Lou & Chen Jiang. (2013) Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease. Pharmaceutical Research 30:10, pages 2549-2559.
Crossref
Thomas Müller. (2013) Pharmacokinetic Considerations for the Use of Levodopa in the Treatment of Parkinson Disease. Clinical Neuropharmacology 36:3, pages 84-91.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.